Single staff cystectomy in a low-volume center: Oncological outcomes and complications.


Journal

Canadian Urological Association journal = Journal de l'Association des urologues du Canada
ISSN: 1911-6470
Titre abrégé: Can Urol Assoc J
Pays: Canada
ID NLM: 101312644

Informations de publication

Date de publication:
Nov 2021
Historique:
pubmed: 18 5 2021
medline: 18 5 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

Radical cystectomy (RC) with bilateral pelvic lymph node dissection (PLND) is a complex surgical procedure, associated with substantial perioperative complications. Previous studies suggested reserving it to high-volume centers in order to improve oncological and perioperative outcomes. However, only limited data exist regarding low-volume centers with highly experienced surgeons. We aimed to assess oncological and perioperative outcomes after RC performed by experienced surgeons in the low-volume center of Luzerner Kantonsspital, Lucerne, CH. We retrospectively analyzed the data of 158 patients who underwent RC and PLND performed between 2009 and 2019 at a single low-volume center by three experienced surgeons, each having performed at least 50 RCs. Complications were graded according to the 2004 modified Clavien-Dindo grading system. A total of 110 patients (70%) received an incontinent urinary diversion (ileal conduit or ureterocutaneostomy) and 48 patients (30%) received a continent urinary diversion (ileal orthotopic neobladder, ureterosigmoidostomy, or Mitrofanoff pouch). Median operating time was 419 minutes (interquartile range [IQR] 346-461). Overall, at RC specimen, 71.5% of patients had urothelial carcinoma, 12.6% squamous, 3.1% sarcomatoid, 1.2% glandular, and 0.6% small cell carcinoma. Median number of lymph nodes removed was 23 (IQR 16-29.5). Positive margins were found in eight patients (5.1%). Overall five-year survival rate was 52.4%. The complication rate was 56.3%: 143 complications were found in 89 patients, 36 (22.8%) with Clavien ≥3. The 30-day mortality rate was 2.5%. RC could be safely performed in a low-volume center by experienced surgeons with comparable outcomes to high-volume centers.

Identifiants

pubmed: 33999810
pii: cuaj.7171
doi: 10.5489/cuaj.7171
pmc: PMC8641899
doi:

Types de publication

Journal Article

Langues

eng

Pagination

E582-E587

Références

J Urol. 2014 Mar;191(3):681-7
pubmed: 24099746
Investig Clin Urol. 2017 May;58(3):171-178
pubmed: 28480342
Nat Rev Urol. 2018 Nov;15(11):686-692
pubmed: 30104615
Eur Urol. 2020 Nov;78(5):719-730
pubmed: 32624275
Postgrad Med J. 2007 Aug;83(982):556-60
pubmed: 17675551
Eur Urol. 2016 Jul;70(1):93-105
pubmed: 26935559
Urology. 2018 Apr;114:87-94
pubmed: 29305205
J Urol. 2007 Dec;178(6):2308-12; discussion 2313
pubmed: 17936804
BJU Int. 2014 Jul;114(1):46-55
pubmed: 24219110
Eur Urol. 2017 Mar;71(3):462-475
pubmed: 27375033
BJU Int. 2017 May;119 Suppl 5:26-32
pubmed: 28544301
BJU Int. 2011 Oct;108(8 Pt 2):E258-65
pubmed: 21314812
J Urol. 2013 Feb;189(2):474-9
pubmed: 23017529
J Urol. 2010 Jun;183(6):2165-70
pubmed: 20399473
J Urol. 2010 Feb;183(2):510-4
pubmed: 20006884
J Urol. 2010 Jul;184(1):87-91
pubmed: 20478596
BJU Int. 2017 Aug;120(2):239-245
pubmed: 28192632
J Urol. 2016 May;195(5):1368-1376
pubmed: 26551296
Eur Urol. 2011 May;59(5):775-83
pubmed: 21310525
World J Urol. 2009 Feb;27(1):33-8
pubmed: 19020884
Eur Urol. 2020 Feb;77(2):223-250
pubmed: 31753752
Urol Oncol. 2007 Jan-Feb;25(1):66-71
pubmed: 17208142
Eur Urol. 2015 Mar;67(3):363-75
pubmed: 25582930
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Eur Urol Focus. 2016 Apr;2(1):19-29
pubmed: 28723446
Bladder Cancer. 2016 Jul 27;2(3):319-327
pubmed: 27500199
Ann Oncol. 2019 Nov 1;30(11):1697-1727
pubmed: 31740927
Urol Oncol. 2013 Nov;31(8):1663-9
pubmed: 22687566
Patient Prefer Adherence. 2016 Oct 28;10:2181-2187
pubmed: 27822019
BJU Int. 2019 May 4;:
pubmed: 31055865
Eur Urol Focus. 2020 Sep 15;6(5):975-981
pubmed: 30772360

Auteurs

Philipp Baumeister (P)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Davide Galioto (D)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Marco Moschini (M)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Chiara Lonati (C)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Stefania Zamboni (S)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Luca Afferi (L)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Patrick Stucki (P)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Hansjörg Danuser (H)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Dirk Lehnick (D)

Department of Biostatistics, Luzerner Kantonsspital, Lucerne, Switzerland.

Livio Mordasini (L)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Agostino Mattei (A)

Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.

Classifications MeSH